ISNS is recognized worldwide for its contributions to the detection of neonatal conditions and the prevention of their adverse outcomes through excellence in neonatal screening.
To enhance the quality of neonatal screening and medical services through dissemination of information, guidelines and best practices that benefit all family members and their babies by helping to ensure protection of babies from life-quality threatening conditions, such as phenylketonuria, congenital hypothyroidism, severe combined immunodeficiency, cystic fibrosis, hemoglobinopathies and many others.
If you do not receive the ISNS Newsletter please notify the ISNS Office. The archive containing most Newsletters can be found at https://membership.isns-neoscreening.org/member/files/ISNS_society_documents/Newsletters
If you change your email address please notify the ISNS Office.
Welcome to the website of the International Society for Neonatal Screening (ISNS).
This society is aiming to advance screening for neonatal and infant sicknesses and disorders, worldwide.
ISNS has around 470 members in more than 70 different countries. Most members have a professional (para)medical background but a few are involved in parents or patients advocacy groups.
For more information about ISNS visit the ISNS-Info section (see above).
ISNS welcomes new members who have demonstrated an active interest in neonatal screening.
The location of members worldwide as of Jan. 1, 2017, is shown in the picture on the right. Countries/states with at least one member are shown in blue, others in grey.
How do I become a member?
Please read this and subsequently click on the button Member application.
Why should I join as a member?
As a member you are entitled to see the privileged pages containing specific news items, a monthly neonatal screening literature service and a discount to ISNS-related conferences. Under certain conditions you may apply for travel grants to such conferences. Having access to the on line membership directory you have easier access to other members sharing specific interests.
The ISNS supervises a journal, the International Journal of Neonatal Screening, published by MDPI, Basel, Switzerland.
For information, please follow this link.
Members are stimulated to use this journal for their publications.
Five United States states now conduct screening test for Spinal Muscular Atrophy on newborns: Missouri, Minnesota, New York, Pennsylvania and Utah. According to an Advisory Committee on Heritable...Read more
On 30th January 2019 Fabio Massimo Castaldo, Vice...Read more